hotspot -WSS

hotspot

author：hotspot 2025-10-01 18:22:51 - browse：7166

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Three issues to watch in global health in 2024

WSS

New England Journal of Medicine addresses racist history, slavery

Risky weight loss products often used by teens globally, per study

Caregivers of transplant patients call for more support, training

Venture capitalist Bob Kocher on the state of digital health

JPM 2024: Nvidia claims we're in biological revolution. Are we?

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

entertainment

hotspot

knowledge

Affirmative action in medical school literally saved lives

Wearables generate powerful data but its not useful to doctors, yet

Virginia high school admissions case could be legal follow

NVIDIA and Google execs on the future of AI and drug discovery

Medical leaders decry Supreme Court decision on affirmative action

Addiction experts warn against a second 'war on drugs'

BioMarin wins approval for gene therapy to treat hemophilia A

Arc Institute generative AI designs new CRISPR systems

Bright Health sells Medicare Advantage business to Molina

Health and fitness trackers are measuring the wrong things

hotspot

Heart disease and mental health: A look at cardiac psychology

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Health and fitness trackers are measuring the wrong things

Generative AI mines health records to identify patients’ social needs

How I ended up pumping milk in a bathroom stall at JPM 2024

Helping hospitals and community health centers plan for resilience

hotspot

focus

hotspot

Wikipedia